References
1. Zoetis Inc. Data on file, Animalytix, Inc. Equine Vaccine MAT dose sales data June 2023.
2. American Association of Equine Practitioners. Vaccination Guidelines. https://aaep.org/guidelines/vaccination-guidelines. Accessed October 11, 2023.
3. MacKay R. Tetanus. In: Sellon DC, Long M, eds. Equine Infectious Diseases, 2nd ed. St. Louis, MO: Saunders Elsevier, 2007:368-372.
4. Ma X, Monroe BP, Cleaton JM, et al. Rabies Surveillance in the United States during 2016. J Am Vet Med Assoc.2018;252(8):945-957.
5.The American Society for the Prevention of Cruelty to Animals. Pet Statistics.https://aspca.org/animalhomelessness/shelterintake-and-surrender/pet-statistic. Accessed Sept. 8, 2023.
6. American Horse Council; Washington, D.C; 2017 Economic Impact of the U.S. Horse Industry.
7. American Association of Equine Practitioners. Equine Influenza Guidelines. Accessed December 2022.
8. Zoetis Inc. Data on file. Study Report No. B951R-US-20-160, Zoetis Inc.
9. Animalytix Segment Data, Equine Vaccines, MAT June 2023 (accessed June 20, 2023).
10. Zoetis Inc. Data on file, ZMR sales data for CORE EQ INNOVATOR® and CORE EQ INNOVATOR® + V. Zoetis Inc., 2018-2022.
11. Zoetis Inc. Data on file, Study Report No. B951R-US-14-056, Zoetis Inc.
12. Zoetis Inc. Data on file, Study Report No. B951R-US-16-106, Zoetis Inc.
13. Zoetis Inc. Data on file, Study Report No. 18EQRGBIO-01-02, Zoetis Inc.
14. Dilai M, et all. Serological investigation of racehorse vaccination against equine influenza in Morocco. Veterinary Microbiology.223. 2018. 153-159
15. Zoetis Inc. Data on file, Study Report No. 19EQRGBIO-01-02, Zoetis Inc.
16. Zoetis Inc. Data on file, Study Report No. 21EQRGBIO-01-01, Zoetis Inc.
17. Zoetis Inc. Data on file, Study Report No. 22EQRGBIO-01-01, Zoetis Inc.
18. Zoetis Inc. Data on file, Study Report No. 23EQRGBIO-01-01, Zoetis Inc.
19. Zoetis Inc. Data on file, Study Report No. 14OREQBIO-1, Zoetis Inc.
20. Davis EG, Zhang Y, Tuttle J, Hankins K, Wilkerson M. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine. Vet Immunol Immunopathol. 2008;126(3-4):293-301.
21. Horohov DW, Dunham J, Liu C, et al. Characterization of the in situ immunological responses to vaccine adjuvants. Vet Immunol Immunopathol. 2015;164(1-2):24-29.
22. Epp T, Waldner C, Townsend HGG. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003. Equine Vet J. 2007;39:498-503.
23. Bryans JT, Allen GP. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus 1. Dev Biol Stand. 1982;52:493-498.
24. Tengelsen LA, Yamini B, Mullaney TP, et al. A 12-year retrospective study of equine abortion in Michigan. J Vet Diagn Invest. 1997;9(3):303-306.
25. Giles RC, Donahue JM, Hong CB, et al. Causes of abortion, stillbirth, and perinatal death in horses: 3,527 cases (1986-1991). J Am Vet Med Assoc. 1993;203(8):1170-1175.
26. Hong CB, Donahue JM, Giles RC, et al. Equine abortion and stillbirth in central Kentucky during 1988 and 1989 foaling seasons. JVet Diagn Invest. 1993;5(4):560-566.